The report, “Site of Service Cost Differences for Medicare Patients Receiving Chemotherapy,” was commissioned by McKesson Specialty Health on behalf of The US Oncology Network. The researchers studied 10 common cancer types that use chemotherapy as a treatment and analyzed costs for Medicare patients from 2006-2009.
They found that the per-patient-per-month allowed costs were $4,361 for those receiving chemotherapy in a physician office and $4,981 for those receiving the treatment in a hospital outpatient setting. Over the course of a year, this difference would grow to approximately $47,500 for physician offices versus roughly $54,000 for hospital outpatient settings.
Related Articles on Oncology Costs:
10 Statistics on Oncologist Compensation
Expert Panel Says Cancer Policy Needs “Radical Shift” to Provide Affordable Care
Study: Chemotherapy, ED Visits Among Top Drivers of Cancer Care Costs
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
